Azitra, Inc. (AZTR)
NYSEAMERICAN: AZTR · Real-Time Price · USD
0.2039
-0.0081 (-3.82%)
May 22, 2026, 4:00 PM EDT - Market closed
Azitra Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
3.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 7.50K | -678.50K | -98.91% |
| Dec 31, 2023 | 686.00K | 402.00K | 141.55% |
| Dec 31, 2022 | 284.00K | 174.00K | 158.18% |
| Dec 31, 2021 | 110.00K | -315.00K | -74.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ensysce Biosciences | 4.71M |
| 60 Degrees Pharmaceuticals | 1.31M |
| VivoSim Labs | 142.00K |
| AIM ImmunoTech | 94.00K |
| Soligenix | 2.34K |
AZTR News
- 3 days ago - Azitra files to sell 255.7M shares of common stock for holders - TheFly
- 12 days ago - Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates - PRNewsWire
- 18 days ago - Azitra granted new U.S. patent protecting ATR-12 program - TheFly
- 19 days ago - Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program - PRNewsWire
- 27 days ago - Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris - PRNewsWire
- 2 months ago - Why Is Azitra Inc Stock (AZTR) Up Today? - TipRanks
- 2 months ago - Azitra Inc trading resumes - TheFly
- 2 months ago - Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million - PRNewsWire